Lettmann Jason's Insider Trades & SAST Disclosures
Lettmann Jason's most recent trade in Alx Oncology Holdings Inc was a trade of 125,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on April 11, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Lettmann Jason.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alx Oncology Holdings Inc | Jason Lettmann | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2025 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 42,000 | 212,270 | - | 0 | Common Stock | |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 1.15 per share. | 19 Feb 2025 | 2,159 | 170,270 | - | 1.2 | 2,483 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 478,000 | 478,000 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Lettmann Jason | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.58 per share. | 14 Aug 2024 | 2,191 | 169,429 | - | 2.6 | 5,653 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 11.31 per share. | 14 Mar 2024 | 4,400 | 171,620 | - | 11.3 | 49,771 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 190,000 | 190,000 | - | - | Employee Stock Option | |
| Alx Oncology Holdings Inc | Lettmann Jason | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 60,000 | 167,220 | - | 0 | Common Stock | |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 20,200 | 20,200 | - | - | Stock option (right to buy) | |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 12,004 | 12,004 | - | - | Common Stock (right to buy) | |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 27.49 per share. | 13 Dec 2021 | 286,496 | 2,101,291 | - | 27.5 | 7,875,775 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 26.48 per share. | 13 Dec 2021 | 17,169 | 2,110,800 | - | 26.5 | 454,635 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.29 per share. | 13 Dec 2021 | 11,945 | 2,127,969 | - | 25.3 | 302,089 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 26.48 per share. | 13 Dec 2021 | 2,339 | 287,792 | - | 26.5 | 61,937 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 28.37 per share. | 13 Dec 2021 | 2,196 | 2,099,095 | - | 28.4 | 62,301 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.29 per share. | 13 Dec 2021 | 1,627 | 290,131 | - | 25.3 | 41,147 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 29.60 per share. | 13 Dec 2021 | 1,329 | 2,097,766 | - | 29.6 | 39,338 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 27.49 per share. | 13 Dec 2021 | 1,296 | 286,496 | - | 27.5 | 35,627 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.23 per share. | 13 Dec 2021 | 440 | 2,097,326 | - | 30.2 | 13,301 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 28.37 per share. | 13 Dec 2021 | 299 | 286,197 | - | 28.4 | 8,483 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 29.60 per share. | 13 Dec 2021 | 181 | 286,016 | - | 29.6 | 5,358 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.23 per share. | 13 Dec 2021 | 60 | 285,956 | - | 30.2 | 1,814 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 12,004 | 12,004 | - | - | Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 1,831,027 | 2,268,087 | - | - | Common Stock | ||
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 1,633,743 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 1,498,984 | 2,023,469 | - | - | Common Stock | ||
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 683,523 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 664,660 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 21 Jul 2020 | 378,000 | 378,000 | - | 19 | 7,182,000 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 249,632 | 309,222 | - | - | Common Stock | ||
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 222,752 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 150,801 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 137,286 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 111,528 | 120,212 | - | - | Common Stock | ||
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 88,704 | 107,220 | - | - | Common Stock | ||
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 78,175 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 59,998 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 39,758 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 38,660 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 21 Jul 2020 | 22,000 | 22,000 | - | 19 | 418,000 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 18,705 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 11,110 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 10,529 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 8,175 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Alx Oncology Holdings Inc | Jason Lettmann | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 24,009 | 24,009 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges